MP
MapLight Therapeutics, Inc. (MPLT)
NASDAQ·Healthcare·Biotechnology
$27.14
-2.95%
Mkt Cap $15.62M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$43.00
Range $36.00 – $48.00
Implied Upside
+58.5%
Consensus $43.00 vs current $27.14